Contribute Try STAT+ Today

Good morning, everyone, and welcome to another working week, albeit an abbreviated one on this side of the pond thanks to an extended weekend respite. Of course, this means a game of catchup with those of you located in other regions. So on that note, we are firing up the trusty coffee kettle and brewing cups of stimulation. Our choice today is cinnamon mocha. Yum. Meanwhile, we have assembled the usual menu of tidbits, although it does appear a bit quiet at the moment. No matter, this will not last long. Have a great day, and keep in touch. …

As Purdue Pharma attempts to win a controversial reorganization plan in bankruptcy court, the drug maker is also seeking approval for $34.7 million in employee bonuses, including $2.1 million for the chief executive officer, STAT reports. The request raises the possibility of yet another round of outrage over company bonuses. Currently, about 500 Purdue employees are eligible for bonuses, or $67,000 per person. By contrast, the reorganization plan sets a maximum payout of $48,000 to individual claimants.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment